logo
Ozempic could be hurting your gym gains — with potentially dangerous consequences

Ozempic could be hurting your gym gains — with potentially dangerous consequences

Independenta day ago
The popular weight loss drug Ozempic has been used by millions of Americans for years. Now, researchers warn that the drug has shown some concerning impacts to muscle mass and strength in mice.
New findings suggest muscle mass is altered less than expected while taking the diabetes drug, but that muscles may still get weaker over time. Ozempic-induced weight loss decreased lean mass — or muscle mass without fat — by around 10 percent, the University of Utah Health team said.
Most of that weight loss was from tissue and the liver; the organ shrunk by nearly half its size. Some skeletal muscles, which are attached to bones and responsible for movement, also shrank, while other muscles remained the same size as before Ozempic.
"In clinical trials for Wegovy or Ozempic we did not specifically study the medicine's impact on muscle mass. In a sub-study of 140 patients with a BMI of 40 or less conducted as part of the STEP 1 trial, dual-energy x-ray absorptiometry (DEXA) analyses suggested that treatment with Wegovy® was accompanied by reductions in both fat mass and lean body mass, with a greater reduction in fat mass than lean body mass," a spokesperson for Novo Nordisk told The Independent on Tuesday.
"We recommend that any patients experiencing side effects while taking Wegovy or Ozempic contact their healthcare provider," they said.
Muscle and strength loss in human aging, also known as sarcopenia, can result in trouble with balance and walking, according to the Cleveland Clinic. It's a condition often linked to obesity, osteoporosis, arthritis, and chronic diseases, including cancer.
Still, the study was done in mice and not humans. More research needs to be done to understand if similar changes to organ size could happen in humans and if there are any associated health risks. Notably, loss of organ mass, including the liver, is expected as a part of healthy weight loss, without affecting the organs' function. loss of fat can also result in loss of muscle without affecting the overall quality of life, the researchers noted.
'If we want to really help the individuals who may be losing muscle mass, then we need to know that they're actually losing muscle mass,' Dr. Katsu Funai, an associate professor of nutrition and integrative physiology in the University of Utah College of Health, said in a statement. 'We have data in mice that suggest that things are not as straightforward as they might seem.'
But, it's not just muscle mass that was affected. In tests of force and strength, some of the mice muscles' strength decreased as they lost weight — even without losing muscle mass. But, in others, strength was unchanged. Why this happens is not yet understood, but in older humans, losing strength while taking Ozempic could be particularly worrisome.
'The loss of physical function is a strong predictor of not just quality of life but longevity,' Funai said.
Of course, previous research has found Ozempic to have more beneficial side effects, in addition to helping address the nation's obesity epidemic. A new study linked Ozempic to slower rates of aging, according to New Scientist. That builds on similar research released last year. The drug has also been tied to a reduced risk of dementia in people with type 2 diabetes, and protection against heart disease. Ozempic has not been approved by the U.S. Food and Drug Administration.
Regardless of their findings, the researchers warned people not to draw hasty and unfounded conclusions. In people, for example, obesity is associated with less physical activity, whereas mice don't become less active. Humans also become overweight for a multitude of factors, including genetics and age. For mice, it was because they ate a diet that was high in fat.
'There remains a significant need for validation in humans, especially concerning muscle strength,' Dr. Takuya Karasawa, a postdoctoral researcher at the university's molecular medicine program, said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Stuck astronaut Butch Wilmore retires from NASA less than 5 months after extended spaceflight
Stuck astronaut Butch Wilmore retires from NASA less than 5 months after extended spaceflight

The Independent

time9 minutes ago

  • The Independent

Stuck astronaut Butch Wilmore retires from NASA less than 5 months after extended spaceflight

One of NASA's two previously stuck astronauts has retired from the space agency, less than five months after his unexpectedly long spaceflight came to an end. NASA announced Butch Wilmore's departure on Wednesday. Wilmore and Suni Williams launched last summer as test pilots on Boeing's first astronaut flight. What should have been a weeklong trip to the International Space Station turned into a stay of more than nine months because of Boeing's malfunctioning Starliner. Starliner came back empty, and Wilmore and Williams returned to Earth in March with SpaceX. Wilmore, 62, had already retired from the Navy. Williams, 59, also a retired Navy captain, is still with NASA. She joined Second Lady Usha Vance at Johnson Space Center in Houston earlier this week, taking part in a summer reading challenge for schoolchildren. Selected as an astronaut in 2000, Wilmore logged 464 days in orbit over three missions. His final spaceflight made up nearly two-thirds of that total: 286 days. 'Throughout his career, Butch has exemplified the technical excellence of what is required of an astronaut," NASA's chief astronaut Joe Acaba said in a statement. 'As he steps into this new chapter, that same dedication will no doubt continue to show in whatever he decides to do next.' ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

FDA flags problems with two Boston Scientific heart devices tied to injuries and deaths
FDA flags problems with two Boston Scientific heart devices tied to injuries and deaths

The Independent

timean hour ago

  • The Independent

FDA flags problems with two Boston Scientific heart devices tied to injuries and deaths

U.S. health regulators are warning doctors and patients about safety issues with two separate Boston Scientific heart devices recently linked to injuries and deaths. The Food and Drug Administration issued two alerts Wednesday about electrical problems tied to the company's heart-zapping defibrillator systems and a separate issue with a heart implant used to reduce stroke risk. The agency said the company's Endotak Reliance defibrillator wires can become calcified, leading to failures in delivering life-saving shocks to the heart, according to the FDA. Defibrillators are surgically placed in the upper chest, where they monitor irregular heartbeats and use electrical shocks to jolt the heart back to normal. As of July 24, Boston Scientific has reported 386 serious injuries and 16 deaths associated with this issue, the agency said. Ten of the deaths were judged to be due to the device failing to function properly, the company said in an email. Four were linked to attempts to surgically remove the devices from patients and two others were deemed unrelated to the implants. Boston Scientific's wires were distributed between 2002 and 2021 and are no longer available, the company noted in its letter to doctors. Some patients will need to have the devices replaced, though physicians should weigh the risks of the removal procedure. In a separate notice, the FDA said Boston Scientific recently updated instructions for implanting its Watchman device, which closes a portion of the heart's left atrium to reduce the risk of stroke. In a letter to physicians, the company noted that there is an increased risk of blockages in the bloodstream depending on the level of anesthesia for patients undergoing the initial implantation procedure. Watchman is an alternative to long-term treatment with blood thinners for patients at increased risk of stroke. As of July 30, the company has reported 120 serious injuries and 17 deaths related to the issue, the FDA said. A company investigation concluded that the safety issue 'is not associated with the design or manufacture of any component of the Watchman system. Heart devices, including defibrillators and other implants, are Boston Scientific's largest business, making up two-thirds of its $5 billion in revenue for the most recent quarter. Shares of Boston Scientific Corp. fell nearly 1.8 percent Wednesday to close at $102.95 in trading. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

Doctors decry RFK Jr decision to slash mRNA vaccine grants: ‘Our nation will pay in lives'
Doctors decry RFK Jr decision to slash mRNA vaccine grants: ‘Our nation will pay in lives'

The Independent

time2 hours ago

  • The Independent

Doctors decry RFK Jr decision to slash mRNA vaccine grants: ‘Our nation will pay in lives'

Doctors are sounding the alarm about potentially deadly consequences of the Trump administration's decision to slash $500 million in funding for mRNA vaccine development, saying the 'deeply troubling' move could leave Americans defenseless in the face of a biological attack, or another pandemic. Leading physicians and vaccine specialists were among the medical and scientific experts who told The Independent that years of progress had been lost, including the lessons learned during Covid. 'This is a deeply troubling development that will, in the short term, leave the U.S. poorly prepared for a pandemic or biological attack, and, in the long term, stifle medical innovation upon which so many Americans depend for life saving cures,' Dr. Jennifer Nuzzo, director of the Pandemic Center at the Brown University School of Public Health, said in an email. Health and Human Services Sec. Robert F Kennedy Jr announced Tuesday the termination of 22 projects, including contracts with Emory University and Covid shot-makers Moderna, Pfizer, and AstraZeneca. 'We're shifting that funding toward safer, broader vaccine platforms that remain effective even as viruses mutate,' Kennedy said. While Kennedy, who has questioned Covid vaccine safety and previously falsely claimed the measles vaccine contains fetal debris, cited a review of 'the science' in terminating the project. But Dr Nuzzo said the 'attack on mRNA vaccine technology rests on phony and false claims, proven so by real facts and evidence'. She continued: 'It is, however, aligned with his long-held and deadly determination to sow doubts about all vaccines and to restrict the ability of the American people to access vaccines. Our nation will pay dearly for this decision in dollars and lives.' The mRNA vaccines work differently from traditional vaccines, which inject a weakened virus into the body to trigger an immune response. Instead, mRNA vaccines teach the cells to make small and harmless pieces of virus that trigger the same response. The anti-vaxxer movement and Kennedy have inaccurately claimed that mRNA Covid vaccines are deadly and that vaccines 'poisoned' American children but they are safe according to decades of public research and countless government assessments. The only mRNA vaccines currently available are Covid vaccines. They were able to be brought to market so quickly because scientists didn't need the virus to make them, and the vaccine material can be created in a lab. Research also has been underway to produce mRNA vaccines against cancer and other infectious diseases, work that has been going on for decades. 'While most would associate mRNA vaccine technology with Covid, it was in development for over half a century and the U.S. government's partnership in that development goes back decades,' Richard Hughes IV, a former vice president of public policy at mRNA vaccine manufacturer Moderna who teaches vaccine law at George Washington University Law School, told The Independent. 'These kinds of partnerships are what drive innovation and save us from public health emergencies. When we lose this kind of progress, we create future public health risks.' Scientists know it's only a matter of time before the next pandemic, when vaccines may once again be needed en masse. Dr. Jake Scott, an infectious diseases physician and Clinical Associate Professor at Stanford University School of Medicine, said that no other vaccine technology could provide the world with a vaccine as quickly as is need during a pandemic. He noted that Kennedy's decision was rewriting the history of the pandemic and the lifesaving track record of mRNA vaccines. 'Vaccines aren't some niche drug. We're not talking about some rare skin cancer drug. We're talking about medicines that apply to literally every human being on the planet and we should have learned from the Covid pandemic that everyone is potentially susceptible to pandemic,' Dr Scott said. In what experts have labeled an assault on science, the Trump administration has eliminated grants and dramatically reduced the workforce of federal health and science agencies. Theses actions, and Kennedy's mRNA cuts, are likely in response to government vaccine mandates and restrictions, Dr. Paul Offit, a vaccine expert at Children's Hospital of Philadelphia, told The Independent. 'It's a tremendous step backward, the is politicization of science, and RFK Jr., who has been a lifelong anti-vaccine propagandist and science denialist, is now making policy,' he said.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store